deltatrials
Completed PHASE4 NCT00111566

BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention

Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention

Sponsor: Cardiology Research UBC

Conditions Coronary Artery Disease Myocardial Infarction
Interventions eptifibatide
Updated 5 times since 2017 Last updated: Nov 27, 2013 Started: Dec 31, 2004 Primary completion: Jul 31, 2007 Completion: Aug 31, 2007

Listed as NCT00111566, this PHASE4 trial focuses on Coronary Artery Disease and Myocardial Infarction and remains completed. Sponsored by Cardiology Research UBC, it has been updated 5 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardiology Research UBC
  • University of British Columbia
Data source: Cardiology Research UBC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Vancouver, Canada